Leiden, Netherlands · Founded 2021 · Privately Held (backing)
Developer of small-molecule biotech program designed for the development of innovative therapies targeting synthetic lethal metabolic dependencies in cancer. Alesta Therapeutics is based in Leiden, Netherlands and was founded in 2021. It has raised $68.3 million.
Last price · $/share
—
Implied valuation
—
Total raised
$68.3M
Last round
—
Cap table — not yet on record
Alesta Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Alesta Therapeutics with a free account
·Watch Alesta Therapeutics: the Monday email on marks, rounds and moves
